GSK plc
Other OTCTotal Valuation
GSK plc carries a market capitalization of 103.62B, placing it among publicly traded companies globally. Its enterprise value stands at 90.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 103.62B |
| Enterprise Value | 90.58B |
Share Statistics
GSK plc currently has 4.01B shares outstanding.
| Shares Outstanding | 4.01B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
GSK plc trades at a trailing price-to-earnings ratio of 15.79. The price-to-sales ratio is 2.29, and the price-to-book ratio stands at 4.30.
| PE Ratio | 15.79 |
| PS Ratio | 2.29 |
| PB Ratio | 4.30 |
| P/TBV Ratio | -11.61 |
| P/FCF Ratio | 6.81 |
| P/OCF Ratio | 9.14 |
Enterprise Valuation
On an enterprise value basis, GSK plc trades at an EV/EBITDA multiple of 13.18 and an EV/FCF ratio of 7.58. The EV/Sales ratio of 2.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.18 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.73 |
| EV / EBITDA | 13.18 |
| EV / EBIT | 13.18 |
| EV / FCF | 7.58 |
Financial Position
GSK plc maintains a current ratio of 0.82, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 106.18, indicating elevated leverage, while an interest coverage ratio of 9.96 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.82 |
| Quick Ratio | 0.14 |
| Debt / Equity | 106.18 |
| Debt / EBITDA | 2.65 |
| Interest Coverage | 9.96 |
Financial Efficiency
GSK plc posts a return on equity of 29.73 and a return on invested capital of 17.96.
| Return on Equity (ROE) | 29.73 |
| Return on Assets (ROA) | 7.97 |
| Return on Invested Capital (ROIC) | 17.96 |
| Return on Capital Employed (ROCE) | 14.88 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.47 |
Taxes
Over the trailing twelve months, GSK plc has paid 641.00M in income taxes, reflecting an effective tax rate of 10.86.
| Income Tax | 641.00M |
| Effective Tax Rate | 10.86 |
Stock Price Statistics
GSK plc's stock has gained approximately 37.18833% over the past 52 weeks. The 50-day moving average sits at 25.62, while the 200-day moving average is 25.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | 37.18833% |
| 50-Day Moving Average | 25.62 |
| 200-Day Moving Average | 25.66 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, GSK plc generated 33.20B in revenue and converted that into 4.82B in net income, yielding earnings per share of 1.29. EBITDA reached 6.87B, while operating income came in at 6.87B.
| Revenue | 33.20B |
| Gross Profit | 24.15B |
| Operating Income | 6.87B |
| Pretax Income | 5.90B |
| Net Income | 4.82B |
| EBITDA | 6.87B |
| EBIT | 6.87B |
| Earnings Per Share (EPS) | 1.29 |
Balance Sheet
GSK plc holds 3.11B in cash and equivalents against 18.24B in total debt, resulting in a net debt position of -3.10B. Total book value stands at 17.65B, with working capital of -3.97B providing operational flexibility.
| Cash & Cash Equivalents | 3.11B |
| Total Debt | 18.24B |
| Net Debt | -3.10B |
| Equity (Book Value) | 17.65B |
| Book Value Per Share | 4.40 |
| Working Capital | -3.97B |
Cash Flow
GSK plc produced 8.33B in operating cash flow over the past twelve months. After subtracting -3.00B in capital expenditures, free cash flow totaled 5.33B - equivalent to 1.33 per share.
| Operating Cash Flow | 8.33B |
| Capital Expenditures | -3.00B |
| Free Cash Flow | 5.33B |
| FCF Per Share | 1.33 |
Margins
GSK plc operates with a gross margin of 72.73, reflecting its pricing power and cost economics. The operating margin of 20.70 and net profit margin of 14.52 provide insight into operational efficiency.
| Gross Margin | 72.73 |
| Operating Margin | 20.70 |
| Pretax Margin | 17.78 |
| Profit Margin | 14.52 |
| EBITDA Margin | 20.70 |
Dividends & Yields
The company's payout ratio of 46.73 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.66 |
| Dividend Yield | N/A |
| Payout Ratio | 46.73 |
| Shareholder Yield | 5.33 |
| FCF Yield | 14.68 |
Stock Splits
GSK plc's most recent stock split took place on July 19, 2022 with a 5:4 split ratio.
| Last Split Date | 7/19/2022 |
| Split Ratio | 5:4 |
Scores
GSK plc posts an Altman Z-Score of 2.81, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.81 |